Despite the efforts of regulators to reduce levels of complexity within the Latvian regulatory environment and improve conditions to encourage investment, understanding and working with the local regulatory and local pharmacovigilance procedures can be difficult. Increasing collaboration at many levels across the Baltic states, together with regulatory change within Latvia itself reinforces the need for an in-depth understanding of the local regulatory affairs and the development of an appropriate approach to pricing and reimbursement submissions. Access to a local regulatory partner and to local QPPV services is an essential pre-requisite to executing successful market entry and development.

Grove is a healthcare consulting firm and its expertise in Latvia spans four key areas:

• regulatory affairs consulting (including regulatory intelligence)
• pharmacovigilance services
• market access, including pricing and reimbursement applications
• market assessment including opportunity evaluation, regulatory risk assessment, information on medical device regulations and routes to market

GROVE AS YOUR PHARMA CONSULTING PARTNER FOR REGULATORY AFFAIRS, PHARMACOVIGILANCE AND MARKET ACCESS

For over twenty years Grove has successfully provided regulatory, PV and market access services to a wide range of clients to help them navigate the specifics of the Latvian market. With experienced consultants based full-time in the country, clients gain access to an unrivalled depth of local knowledge and understanding in all areas associated with entering and operating in this country.

Pharmaceutical consulting, regulatory affairs, pharmacovigilance, market access and market assessment services are all key areas of Grove expertise.